Results from Optimizing Beta-Blocker Dosage in Female Patients Using the Wearable Cardioverter Defibrillator (OPT-BB Women) were presented at ESC-HF 2026CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results